Percival Barretto-Ko

Deep Dive

Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.

News

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.